Silli Epiphane K, Zheng Zhenjiang, Zhou Xintao, Li Mengfei, Tang Jiali, Guo Ruizhe, Tan Chunlu, Wang Ying
School of Life Sciences and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China.
School of Chinese Medicine Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, 211198, China.
Invest New Drugs. 2024 Oct;42(5):518-530. doi: 10.1007/s10637-024-01455-x. Epub 2024 Aug 18.
Obstacles facing chemotherapeutic drugs for cancers led scientists to load Gemcitabine (GEM) into nanocarriers like liposomes, known for their nontoxicity profile and targeting capacity. The liposomal nanostructures containing GEM were coated with Fucoidan (FU) due to its anti-tumor properties by targeting cancer cells. Thus four different cationic liposomes formulations were prepared by thin-film hydration method in optimal conditions: DOTAP (formulation A); DPPC/DOTAP (4:1 molar ratio, formulation B), DPPC/DMPC/DOTAP (4:1:1 molar ratio, formulation C) and DPPC/DMPC/DOTAP/DSPE-mPEG2000 (4:1:1:0.1 molar ratio, formulation D). They were studied to identify lipid-compositions offering effective GEM-entrapment and successful coating of FU on the liposome surface. Additional qualitative characteristics, such as particle size, polydispersity index, zeta potential, stability and in vitro drug release were then evaluated. Formulation C gave the best GEM-entrapment efficiency (EE) but formed aggregates when coated with FU, giving non-homogenous large size particles then not suitable for effective delivery. It was the same situation with formulation A and B. Only the formulation D showed a good GEM-EE (> 80%) and affinity by successful coating FU from three different algae species. The PEGylated formulation D coated of FU, with regard to storage stability and drug release studies, revealed to be a promising approach on design of optimal drug delivery system.
癌症化疗药物面临的障碍促使科学家们将吉西他滨(GEM)载入脂质体等纳米载体中,脂质体以其无毒特性和靶向能力而闻名。由于岩藻依聚糖(FU)具有靶向癌细胞的抗肿瘤特性,因此将含有GEM的脂质体纳米结构用岩藻依聚糖进行包被。因此,在最佳条件下通过薄膜水化法制备了四种不同的阳离子脂质体制剂:DOTAP(制剂A);DPPC/DOTAP(摩尔比4:1,制剂B),DPPC/DMPC/DOTAP(摩尔比4:1:1,制剂C)和DPPC/DMPC/DOTAP/DSPE-mPEG2000(摩尔比4:1:1:0.1,制剂D)。对它们进行了研究,以确定能有效包载GEM并成功将FU包被在脂质体表面的脂质组成。然后评估了其他定性特征,如粒径、多分散指数、zeta电位、稳定性和体外药物释放。制剂C具有最佳的吉西他滨包封率(EE),但在用FU包被时形成聚集体,产生不均匀的大尺寸颗粒,因此不适合有效递送。制剂A和B也是同样的情况。只有制剂D通过成功包被来自三种不同藻类的FU表现出良好的吉西他滨包封率(>80%)和亲和力。就储存稳定性和药物释放研究而言,用FU包被的聚乙二醇化制剂D被证明是设计最佳药物递送系统的一种有前景的方法。